Hsu et al developed a group of prognostic scores for patients with hepatocellular carcinoma. The authors are from National Yang-Ming University and Taipei Veterans General Hospital in Taiwan.
Patient selection: adult with hepatocellular carcinoma
Parameters:
(1) total tumor volume (TTV) in cubic cm, based on summation of all tumor nodule volumes
(2) serum AFP concentration in ng/mL
(3) Child-Pugh stage (A, B or C)
(4) vascular invasion
(5) MELD score
Parameter |
Finding |
Points |
total tumor volume |
< 50 cubic cm |
0 |
|
50 to 250 |
1 |
|
251 to 500 |
2 |
|
> 500 cubic cm |
3 |
serum AFP |
< 400 ng/mL |
0 |
|
>= 400 ng/mL |
1 |
Child-Pugh stage |
A |
0 |
|
B |
1 |
|
C |
2 |
vascular invasion |
absent |
0 |
|
present |
1 |
MELD score |
< 10 |
0 |
|
10 to 14 |
1 |
|
>= 15 |
2 |
Multiple combinations for these variables were correlated with outcomes.
The model with the best performance was the sum of total tumor volume, Child-Pugh stage and serum AFP concentration.
TTV-CPS-AFP score = TIS score =
= SUM(points for the 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 6
• The higher the score the worse the prognosis.
Score |
50% Cumulative Survival |
0 |
88 months |
1 |
65 moths |
2 |
25 months |
3 |
13 months |
4 |
9.6 months |
5 |
3.6 months |
6 |
1.8 months |
Specialty: Hematology Oncology, Gastroenterology